Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Multicentric, Prospective, Controlled, Randomised Clinical Study of the Device Traumacel FAM Trium in the Post-market Surveillance Phase

NCT05177874 is registered in ClinicalTrials.gov with Bioster, a.s. as lead sponsor.

NCT NCT05177874
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05177874 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Multicentric, Prospective, Controlled, Randomised Clinical Study of the Device Traumacel FAM Trium in the Post-market Surveillance Phase
Lead sponsor
Bioster, a.s.
Phase
Not applicable
Overall status
Completed
Start date
May 18, 2020
Completion date
January 2, 2021
Enrollment
98 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

bleeding, surgical wound